DECEMBER 2022LIFE SCIENCES REVIEW 19Exscientia leverages patient-first artificial intelligence (AI) for efficient AI-based drug discovery, tech-enabled drug development, precision medicine, pharmaceuticals, and technology-driven clinical trials and drug manufacturingExscientiaexscientia.aiThe Germany-based small molecules drug discovery and development solution provider focuses on R&D strategy to favour innovative groundbreaking solutions for organisations within the pharmaceutical and biotechnology sectorScitaris scitaris.comLeveraging innovative hybrid technology, NEUREKA combines nanoelectrodes and sophisticated computational models of neuronal circuits and manipulates their connectivity in cultured neuronal networks with subcellular accuracyNEUREKA neureka.grDeveloped in 2015, Standigm is expertise in Artificial Intelligence, drug discovery, active data parsing, Bot modelling, biological interpretation, target identification, lead generation, Machine Learning, deep learning, drug repurposing, NLP, workflow AI, and AI-driven drug discoveryStandigm standigm.comTOP 10 SMALL MOLECULES DRUG DISCOVERY AND DEVELOPMENT SOLUTIONS PROVIDERS IN EUROPE - 2022Torx is a visual, chemistry aware, web-based platform inspiring discovery chemistry teams to work together, deliver faster, and remove bottlenecks by reimagining the end-to-end process to find a more team-friendly, productivity-centric approachTorx Software torx-software.comX-Chem offers services, products, and solutions that can help accelerate all aspects of drug discovery from screen to candidate by deploying DNA-encoded library (DEL) technology, medicinal chemistry, and artificial intelligence to deliver exponentially better drug discovery solutionsX-Chem x-chemrx.com
< Page 9 | Page 11 >